The company is a SPAC looking to invest in companies operating in the field of legalized medicinal cannabis A special-purpose acquisition company (SPAC) looking for cannabis acquisitions has applied for admission to trading its shares on the Aquis Stock Exchange. , incorporated on 28 August 2018 as an investment vehicle and is designated as a SPAC under the AQSE Growth Market Access Rulebook, says its purpose is to identify investment opportunities and make acquisitions in companies operating in the field of legal medicinal cannabis. The company said it will focus on identifying investment opportunities in companies that provide ancillary products and services that serve the medicinal cannabis sector. T

Sean Hocking, Cannabis Law Report, 05/12/2021 00:30:00

Open article: https://cannabislaw.report/cannabis-focused-spac-pharma-c-investments-plc-applies-for-london-listing/